The reactivity of esophageal cancer cells to recombined EGF was strikingly attenuated after genistein treatment (8 μM) for 9 d, compared with Eca-109 cells treated with recombined EGF alone (Figure 7O, P<0.05). Here, EGF is linked to esophageal cancer.